Comparison between Mahamaya Lifesciences IPO and Turtle Infratrade IPO.
Mahamaya Lifesciences IPO is a SME Fixed Price IPO proposed to list at BSE SME while Turtle Infratrade IPO is a SME Fixed Price proposed to list at BSE SME.
| Mahamaya Lifesciences IPO | Turtle Infratrade IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Fixed Price |
| Listing At | BSE SME | BSE SME |
| Lead Managers | Oneview Corporate Advisors Pvt.Ltd. | Inventure Merchant Banker Services Pvt.Ltd. |
| Registrar | Kfin Technologies Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | ||
| DRHP | DRHP  | DRHP |
| RHP | RHP | |
| Anchor Investor | ||
| IPO Allotment URL |
The total issue size of Mahamaya Lifesciences IPO is up to ₹0.00 Cr whereas the issue size of the Turtle Infratrade IPO is up to ₹10.80 Cr. The final issue price of Mahamaya Lifesciences IPO is and of Turtle Infratrade IPO is ₹40.00 per share.
| Mahamaya Lifesciences IPO | Turtle Infratrade IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹40.00 per share | |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 3000 shares | |
| Fresh Issue Size | 56,38,800 shares | 27,00,000 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹10.80 Cr |
| OFS Issue Size | 5,40,000 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 61,78,800 shares | 27,00,000 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹10.80 Cr |
Mahamaya Lifesciences IPO opens on , while Turtle Infratrade IPO opens on . The closing date of Mahamaya Lifesciences IPO and Turtle Infratrade IPO is , and , respectively.
| Mahamaya Lifesciences IPO | Turtle Infratrade IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | ||
| Issue Close | ||
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | ||
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Mahamaya Lifesciences IPO P/E ratio is , as compared to Turtle Infratrade IPO P/E ratio of 5.4.
| Mahamaya Lifesciences IPO | Turtle Infratrade IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Mahamaya Lifesciences Limited Financial Information (Restated Consolidated)
| Turtle Infratrade Limited Financial Information (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 77.27 | 100.00 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 73.58 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 5.4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹40.88 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 23.67% | 43.89% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 32.38% | 27.77% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹7.41 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 21.16% | 43.89% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Mahamaya Lifesciences IPO Retail Individual Investors (RII) are offered while in Turtle Infratrade IPO retail investors are offered . Qualified Institutional Buyers (QIB) are offered in Mahamaya Lifesciences IPO and in Turtle Infratrade IPO.
| Mahamaya Lifesciences IPO | Turtle Infratrade IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | 1,38,000 shares | |
| QIB | ||
| NII | ||
| RII | ||
| Employee | ||
| Others | ||
| Total |
Mahamaya Lifesciences IPO subscribed in total, whereas Turtle Infratrade IPO subscribed .
| Mahamaya Lifesciences IPO | Turtle Infratrade IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | ||
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | ||
| Employee (times) | ||
| Other (times) | ||
| Total (times) |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
